Recruiting Friedreich Ataxia Studies in New York
About Friedreich Ataxia Clinical Trials in New York
Friedreich ataxia is a rare inherited disease that causes progressive damage to the nervous system and movement problems. It is caused by reduced frataxin protein from a GAA repeat expansion. Treatment includes supportive care, with omaveloxolone recently approved.
There are currently 3 friedreich ataxia clinical trials recruiting participants in New York, NY. These studies are seeking a combined 155 participants. Research is being sponsored by Weill Medical College of Cornell University, Scott Barbuto. Clinical trial participation is free and participants receive study-related medical care at no cost.
Friedreich Ataxia Clinical Trials in New York — FAQ
Are there friedreich ataxia clinical trials in New York?
Yes, there are 3 friedreich ataxia clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New York?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.
Are clinical trials in New York free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.
What friedreich ataxia treatments are being tested?
The 3 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for friedreich ataxia.
Data updated October 17, 2026 from ClinicalTrials.gov